TABLE 2.

Identification of potential PKCβ substrates in MCP-1-treated monocytes compared to a PKCβ inhibitor peptide treated monocytes.

Spot number	Protein name	NCBI accession number	Mol. mass (kDa)	Isoelectric point (pI)	Number of peptides (%sequence. coverage)
1	L-plastin	4504965	70	5.2	5(8%)
2	Glucose-regulated protein	16507237	72	5.0	9(19%)
3	Prolyl 4-hyodroxylase, beta subunit Coronin, actin binding protein, 1A	20070125 5902134	57 51	4.7 6.2	21(36%) 2(4%)
4	Vimentin Tubulin alpha 6	62414289 14389309	53 50	5.0 4.9	2(5%) 2(6%)
5	Calreticulin precursor	4757900	48	4.2	3(6%)
6	Beta actin Albumin precursor	4501885 4502027	42 71	5.2 5.9	12(35%) 3(4%)
7	Rho GDP dissociation inhibitor (GDI) beta	56676393	23	5.1	3(13%)
8	Gelsolin-like capping protein	63252913	38	5.8	4(16%)
9	Protease activator subunit 1 isoform 1	5453990	28	5.7	2(8%)
10	Peroxisomal enoyl- coenzyme A hydratase- like protein	70995211	36	8.1	4(14%)
11	Annexin I	4502101	38	6.5	10(37%)
12	Coronin, actin binding protein, 1A	5902134	51	6.2	1(2%)
13	Enolase I	4503571	47	7.0	23(64%)